ArticlePreventive medicine reports2026
Adult dual and polytobacco use in the United States: Findings from the 2021-2023 National Survey on Drug Use and Health.
Article in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Current Tobacco Use Status Associated with Insufficient Sleep Duration and Sleep Problems Among Non-Hispanic Black and Hispanic Men with Chronic Conditions.Epidemiologia (Basel, Switzerland) · 2026Article
- Accelerating tobacco regulatory science in the United States: The center for rapid surveillance of tobacco.Preventive medicine reports · 2026Article
- Patterns of e-cigarette use by sex and age in Thailand: The National Health Examination Survey 2024-2025.Tobacco induced diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Multiple tobacco product (MTP) use is common among tobacco users. Current, detailed estimates of MTP use patterns among users of different tobacco products can inform tobacco treatment and regulation. Methods: Data were pooled from 2021 to 2023 National Survey on Drug Use and Health (United States) adult respondents. We derived estimates of past-month MTP use, mutually exclusive use patterns, and correlates of MTP use among current tobacco users, and stratified by tobacco product used and age. Results: MTP use was reported by 23.7 % of tobacco users; it was most prevalent among ages 18-25 (34.6 %) and 26-34 (31.0 %). Past-month dual cigarette/e-cigarette use was the most prevalent MTP use pattern (39.6 % of MTP users). Binge drinking, major depressive episode, and illicit drug use were associated with greater odds of MTP use. Older age was associated with lower odds of MTP use, except among ENDS users, where odds of MTP use decreased with older age. Conclusions: MTP use is prevalent among adult tobacco users. We report current, comprehensive estimates of MTP use and associated correlates. MTP use and product use patterns varied by age among users of different products. Findings have implications for clinicians, tobacco treatment specialists, and regulators.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.